Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6235 | 1510 | 29.5 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
575 | 2 | VANCOMYCIN//LINEZOLID//DAPTOMYCIN | 14274 |
6235 | 1 | LINEZOLID//OXAZOLIDINONE//LINEZOLID RESISTANCE | 1510 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LINEZOLID | authKW | 5785390 | 34% | 56% | 510 |
2 | OXAZOLIDINONE | authKW | 1543869 | 14% | 36% | 211 |
3 | LINEZOLID RESISTANCE | authKW | 500149 | 2% | 85% | 29 |
4 | TEDIZOLID | authKW | 289080 | 2% | 62% | 23 |
5 | EPEREZOLID | authKW | 181984 | 1% | 100% | 9 |
6 | CFR GENE | authKW | 143788 | 1% | 89% | 8 |
7 | CFR | authKW | 121722 | 1% | 35% | 17 |
8 | G2576T MUTATION | authKW | 121322 | 0% | 100% | 6 |
9 | RANBEZOLID | authKW | 121322 | 0% | 100% | 6 |
10 | ZAAPS | authKW | 121322 | 0% | 100% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 18678 | 33% | 0% | 502 |
2 | Microbiology | 15202 | 42% | 0% | 634 |
3 | Pharmacology & Pharmacy | 8823 | 45% | 0% | 678 |
4 | Chemistry, Medicinal | 1956 | 11% | 0% | 170 |
5 | Chemistry, Organic | 381 | 9% | 0% | 132 |
6 | Immunology | 108 | 6% | 0% | 90 |
7 | Critical Care Medicine | 42 | 1% | 0% | 21 |
8 | Pediatrics | 40 | 3% | 0% | 43 |
9 | Medicine, General & Internal | 16 | 3% | 0% | 51 |
10 | Chemistry, Analytical | 7 | 3% | 0% | 39 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEV EVALUAT CHEM HERBAL DRUGS ANIM US | 59458 | 1% | 29% | 10 |
2 | FARM ANIM GENET | 54614 | 2% | 10% | 28 |
3 | ANTI INFECT GRP | 40441 | 0% | 100% | 2 |
4 | ANTIINFECT DISCOVERY GRP | 40441 | 0% | 100% | 2 |
5 | ASTRAZENECA DISCOVERY | 40441 | 0% | 100% | 2 |
6 | GLOBAL PRICING | 40441 | 0% | 100% | 2 |
7 | PHARMACOL 7250 209 205 | 40441 | 0% | 100% | 2 |
8 | PROD LIFE CYCLE MANAGEMENT | 40441 | 0% | 100% | 2 |
9 | ANTI INFECT DISCOVERY GRP | 26959 | 0% | 67% | 2 |
10 | EA 1156 | 26959 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 39172 | 14% | 1% | 214 |
2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 22482 | 8% | 1% | 118 |
3 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 17117 | 4% | 1% | 57 |
4 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 9441 | 3% | 1% | 50 |
5 | REVISTA ESPANOLA DE QUIMIOTERAPIA | 4150 | 1% | 2% | 9 |
6 | JOURNAL OF INFECTION AND CHEMOTHERAPY | 3997 | 1% | 1% | 15 |
7 | JOURNAL OF CHEMOTHERAPY | 3919 | 1% | 1% | 22 |
8 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3408 | 4% | 0% | 66 |
9 | SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2380 | 2% | 0% | 25 |
10 | CLINICAL INFECTIOUS DISEASES | 2218 | 3% | 0% | 38 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LINEZOLID | 5785390 | 34% | 56% | 510 | Search LINEZOLID | Search LINEZOLID |
2 | OXAZOLIDINONE | 1543869 | 14% | 36% | 211 | Search OXAZOLIDINONE | Search OXAZOLIDINONE |
3 | LINEZOLID RESISTANCE | 500149 | 2% | 85% | 29 | Search LINEZOLID+RESISTANCE | Search LINEZOLID+RESISTANCE |
4 | TEDIZOLID | 289080 | 2% | 62% | 23 | Search TEDIZOLID | Search TEDIZOLID |
5 | EPEREZOLID | 181984 | 1% | 100% | 9 | Search EPEREZOLID | Search EPEREZOLID |
6 | CFR GENE | 143788 | 1% | 89% | 8 | Search CFR+GENE | Search CFR+GENE |
7 | CFR | 121722 | 1% | 35% | 17 | Search CFR | Search CFR |
8 | G2576T MUTATION | 121322 | 0% | 100% | 6 | Search G2576T+MUTATION | Search G2576T+MUTATION |
9 | RANBEZOLID | 121322 | 0% | 100% | 6 | Search RANBEZOLID | Search RANBEZOLID |
10 | ZAAPS | 121322 | 0% | 100% | 6 | Search ZAAPS | Search ZAAPS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MENDES, RE , DESHPANDE, LM , JONES, RN , (2014) LINEZOLID UPDATE: STABLE IN VITRO ACTIVITY FOLLOWING MORE THAN A DECADE OF CLINICAL USE AND SUMMARY OF ASSOCIATED RESISTANCE MECHANISMS.DRUG RESISTANCE UPDATES. VOL. 17. ISSUE 1-2. P. 1 -12 | 97 | 89% | 28 |
2 | SHAW, KJ , BARBACHYN, MR , (2011) THE OXAZOLIDINONES: PAST, PRESENT, AND FUTURE.ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME. VOL. 1241. ISSUE . P. 48 -70 | 83 | 79% | 103 |
3 | VARDAKAS, KZ , KIOUMIS, I , FALAGAS, ME , (2009) ASSOCIATION OF PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF LINEZOLID WITH INFECTION OUTCOME.CURRENT DRUG METABOLISM. VOL. 10. ISSUE 1. P. 2 -12 | 109 | 78% | 10 |
4 | MICHALSKA, K , KARPIUK, I , KROL, M , TYSKI, S , (2013) RECENT DEVELOPMENT OF POTENT ANALOGUES OF OXAZOLIDINONE ANTIBACTERIAL AGENTS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 21. ISSUE 3. P. 577-591 | 75 | 83% | 36 |
5 | HERRMANN, DJ , PEPPARD, WJ , LEDEBOER, NA , THEESFELD, ML , WEIGELT, JA , BUECHEL, BJ , (2008) LINEZOLID FOR THE TREATMENT OF DRUG-RESISTANT INFECTIONS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 6. ISSUE 6. P. 825-848 | 110 | 71% | 15 |
6 | LONG, KS , VESTER, B , (2012) RESISTANCE TO LINEZOLID CAUSED BY MODIFICATIONS AT ITS BINDING SITE ON THE RIBOSOME.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 56. ISSUE 2. P. 603 -612 | 69 | 73% | 76 |
7 | CATTANEO, D , ALFFENAAR, JW , NEELY, M , (2016) DRUG MONITORING AND INDIVIDUAL DOSE OPTIMIZATION OF ANTIMICROBIAL DRUGS: OXAZOLIDINONES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 12. ISSUE 5. P. 533 -544 | 61 | 79% | 2 |
8 | FERRANDEZ, O , URBINA, O , GRAU, S , (2017) CRITICAL ROLE OF TEDIZOLID IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 11. ISSUE . P. 65 -82 | 60 | 81% | 0 |
9 | VARDAKAS, KZ , NTZIORA, F , FALAGAS, ME , (2007) LINEZOLID: EFFECTIVENESS AND SAFETY FOR APPROVED AND OFF-LABEL INDICATIONS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 8. ISSUE 14. P. 2381-2400 | 74 | 73% | 18 |
10 | CHIAPPINI, E , CONTI, C , GALLI, L , DE MARTINO, M , (2010) CLINICAL EFFICACY AND TOLERABILITY OF LINEZOLID IN PEDIATRIC PATIENTS: A SYSTEMATIC REVIEW.CLINICAL THERAPEUTICS. VOL. 32. ISSUE 1. P. 66-88 | 59 | 82% | 24 |
Classes with closest relation at Level 1 |